Literature DB >> 23706533

Lymph node positive head and neck carcinoma after curative radiochemotherapy: a long lasting debate on elective post-therapeutic neck dissections comes to a conclusion.

R M Hermann1, H Christiansen, R M Rödel.   

Abstract

There has been a long lasting debate, whether planned neck dissections after curative radio(chemo)therapy for locally advanced head and neck squamous cell carcinomas offer some benefit in tumor control or survival. We did a thorough literature research on that topic. The results of several recently published studies are described, summarized, and reviewed. Patients with residual disease in clinical or radiographic examinations (CT or MRI scans) up to 3 months after completion of radiochemotherapy profit from neck dissections. In patients with an initial or delayed clinical complete remission after completion of radiochemotherapy, a neck dissection can be safely omitted. In conclusion, there is no longer evidence for a benefit of prophylactic post-radiochemotherapy neck dissections, but strong evidence for a therapeutic post-radiochemotherapy neck dissection in this group of patients.
Copyright © 2013 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Carcinome épidermoïde des voies aérodigestives supérieures; Chimioradiothérapie; Curage ganglionnaire; Head and neck squamous cell carcinoma; Neck dissection; Radiochemotherapy; Réponse pathologique; Tumor response

Mesh:

Substances:

Year:  2013        PMID: 23706533     DOI: 10.1016/j.canrad.2013.01.018

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  11 in total

1.  [De-intensified chemoradiation therapy for favorable-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma].

Authors:  R M Hermann; H Christiansen
Journal:  Strahlenther Onkol       Date:  2016-04       Impact factor: 3.621

2.  Predictive markers, including total lesion glycolysis, for the response of lymph node(s) metastasis from head and neck squamous cell carcinoma treated by chemoradiotherapy.

Authors:  Goshi Nishimura; Masanori Komatsu; Masaharu Hata; Kenichiro Yabuki; Takahide Taguchi; Masahiro Takahashi; Osamu Shiono; Daisuke Sano; Yasuhiro Arai; Hideaki Takahashi; Yoshihiro Chiba; Nobuhiko Oridate
Journal:  Int J Clin Oncol       Date:  2015-08-14       Impact factor: 3.402

3.  [Restaging PET-CT after radiochemotherapy can spare patients with advanced head and neck cancer from neck dissection provided they are in complete remission].

Authors:  Robert Michael Hermann; Hans Christiansen
Journal:  Strahlenther Onkol       Date:  2016-08       Impact factor: 3.621

4.  [Follow-up ultrasound of head and neck cancer].

Authors:  J Künzel; A Bozzato; S Strieth
Journal:  HNO       Date:  2017-11       Impact factor: 1.284

5.  Imaging strategy for response evaluation to chemoradiotherapy of the nodal disease in patients with head and neck squamous cell carcinoma.

Authors:  Goshi Nishimura; Kenichiro Yabuki; Masaharu Hata; Masanori Komatsu; Takahide Taguchi; Masahiro Takahashi; Osamu Shiono; Daisuke Sano; Yasuhiro Arai; Hideaki Takahashi; Yoshihiro Chiba; Nobuhiko Oridate
Journal:  Int J Clin Oncol       Date:  2015-12-28       Impact factor: 3.402

6.  Persistent lymph nodes after curative chemoradiotherapy for head and neck cancer: imaging predictors of response for decision-making.

Authors:  Alfredo Páez-Carpio; Santiago Medrano-Martorell; Joan Berenguer; Africa Muxí; Isabel Vilaseca; Izaskun Valduvieco; Paola Castillo; Neus Baste; F Xavier Avilés-Jurado; Juan José Grau; Laura Oleaga
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-10-01       Impact factor: 3.236

7.  No benefit for regional control and survival by planned neck dissection in primary irradiated oropharyngeal cancer irrespective of p16 expression.

Authors:  R Maquieira; S K Haerle; G F Huber; A Soltermann; S R Haile; S J Stoeckli; Martina A Broglie
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-10       Impact factor: 2.503

8.  Less may be more: nodal treatment in neck positive head neck cancer patients.

Authors:  Gabriela Studer; Gerhard F Huber; Edna Holz; Christoph Glanzmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-04-29       Impact factor: 2.503

9.  Opportunities and Limits in Salvage Surgery in Persistent or Recurrent Head and Neck Squamous Cell Carcinoma.

Authors:  Gerhard Frank Huber
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

10.  Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?

Authors:  Daniel Dejaco; Christian Uprimny; Gerlig Widmann; David Riedl; Patrizia Moser; Christoph Arnold; Teresa Bernadette Steinbichler; Barbara Kofler; Volker Hans Schartinger; Irene Virgolini; Herbert Riechelmann
Journal:  Cancer Imaging       Date:  2020-09-29       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.